<DOC>
	<DOCNO>NCT01339689</DOCNO>
	<brief_summary>This Phase 2 proof-of-concept study double-blind , randomize , placebo-controlled , 15-week investigation ganaxolone versus placebo treatment Posttraumatic Stress Disorder ( PTSD ) . Up 120 subject enrol randomized receive either ganaxolone placebo 6 week . After 6 wks randomize treatment subject continue 6 wks ganaxolone . The aim study assess efficacy ganaxolone compare placebo treatment PTSD symptoms 6 week treatment use Clinician-Administered PTSD Rating Scale ( CAPS ) . The second aim study evaluate safety tolerability ganaxolone PTSD population .</brief_summary>
	<brief_title>Ganaxolone Posttraumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Pregnanolone</mesh_term>
	<criteria>Key Veteran civilian adult outpatient 1855 year age , primary PTSD define DSMIV least 6 month Must general good healthconfirmed medical history , physical examination , screen laboratory result Negative urine drug screen drug abuse Negative urine pregnancy test female childbearing potential Sexually active subject require use medically acceptable form birth control Key Exclusion Criteria Clinically unstable medical disease ; progressive CNS disorder/disease ; history seizure ( except childhood febrile seizure ) ; moderate severe traumatic brain injury ( TBI ) Females pregnant currently breast feed Current past psychotic disorder , bipolar Type I disorder , dementia Subjects recent drug abuse dependency ( exclude nicotine caffeine ) Subjects unwilling comply require alcohol prohibition trial Current suicidal homicidal ideation necessitate intervention , history suicide attempt past 10 year Subjects pending litigation relate traumatic event Subjects unwilling withhold grapefruit grapefruit juice duration study Subjects receive psychotherapy without stable paradigm least 3 month NonEnglish speaking subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Posttraumatic Stress Disorder</keyword>
	<keyword>pharmacotherapy</keyword>
	<keyword>ganaxolone</keyword>
</DOC>